121 related articles for article (PubMed ID: 11877968)
21. The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer.
Kirollos MM
Br J Urol; 1998 May; 81(5):781-2. PubMed ID: 9634071
[No Abstract] [Full Text] [Related]
22. Urine cytology after flexible cystoscopy.
Hyder Z
BJU Int; 2006 Feb; 97(2):414-5; author reply 415. PubMed ID: 16430658
[No Abstract] [Full Text] [Related]
23. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
24. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
25. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
Loidl W; Schmidbauer J; Susani M; Marberger M
Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
[TBL] [Abstract][Full Text] [Related]
26. Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy.
Asanuma H; Arai T; Seguchi K; Kawauchi S; Satoh H; Kikuchi M; Murai M
J Urol; 2003 Feb; 169(2):718-20. PubMed ID: 12544350
[TBL] [Abstract][Full Text] [Related]
27. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
28. Ultraviolet cystoscopy in patients with bladder cancer.
Whitmore WF; Bush IM
Trans Am Assoc Genitourin Surg; 1965; 57():149-55. PubMed ID: 5855557
[No Abstract] [Full Text] [Related]
29. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy.
Bush IM; Whitmore WF
J Med Soc N J; 1967 Feb; 64(2):56-60. PubMed ID: 5231700
[No Abstract] [Full Text] [Related]
30. Bladder tumors: virtual MR cystoscopy.
Suleyman E; Yekeler E; Dursun M; Zorba UO; Tunc M; Tunaci A; Acunas B
Abdom Imaging; 2006; 31(4):483-9. PubMed ID: 16568363
[TBL] [Abstract][Full Text] [Related]
31. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
Yossepowitch O; Herr HW; Donat SM
J Urol; 2007 Apr; 177(4):1277-82; discussion 1282. PubMed ID: 17382711
[TBL] [Abstract][Full Text] [Related]
32. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
33. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
34. [Fluorescence diagnosis and photodynamic therapy in urology].
Stepp H; Waidelich R
Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533
[TBL] [Abstract][Full Text] [Related]
35. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder.
Bryan RT; Billingham LJ; Wallace DM
BJU Int; 2008 Mar; 101(6):702-5; discussion 705-6. PubMed ID: 18005206
[TBL] [Abstract][Full Text] [Related]
36. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
37. Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy?
Karl A; Tritschler S; Stanislaus P; Gratzke C; Tilki D; Strittmatter F; Knüchel R; Stief CG; Zaak D
BJU Int; 2009 Feb; 103(4):484-7. PubMed ID: 18793301
[TBL] [Abstract][Full Text] [Related]
38. Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal.
Kipp BR; Halling KC; Campion MB; Wendel AJ; Karnes RJ; Zhang J; Sebo TJ
J Urol; 2008 Apr; 179(4):1296-301; discussion 1301. PubMed ID: 18289582
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
[TBL] [Abstract][Full Text] [Related]
40. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
